Health TrialsbyHealthPanel

Hierarchy of Effects of Laboratory Markers and Their Interaction With Comorbidity Concerning Outcome and Personalized Treatment of Trauma Patients in Emergency Care and Rehabilitation

ConditionsPostoperative ComplicationsSurgical Site InfectionWound InfectionNon-healing WoundPseudarthrosisBone InfectionPneumoniaNosocomial Infection
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-67
SponsorDepartment of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu

About this trial

At least ten percent of trauma patients suffer from any sort of complication. The study aims to identify a risk factor profile to early identify trauma patients at risk.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

acute long bone fracture (humerus, ulna, radius, femur, tibia) with surgical treatment

Disqualifiers

associated severe injury (ISS > 16)

associated traumatic brain injury

associated traumatic spine injury

dementia

Trial population

patients that suffer from an acute lone bone fracture, require surgical treatment and belong to the age group of being able to working (18 - 67 years old)

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

any complication after long bone fracture

number of patients that suffer from a complication after surgical treatment of a primary long bone fracture

Time frame
6 months, one year
2

Clavien Dindo Classification

Clavien Dindo Classification classifies surgical complications. All patients will be classified according to Clavien Dindo after 6 months and one year.

Time frame
6 months, one year

Secondary outcomes

1

Charlson Comorbidity Index (CCI)

Charlson Comorbidity Index classifies comorbidities of patients. All particiapants will be screened for their comorbidities and classified according to CCI.

Time frame
Initially
2

number of medications

Intake of medication will be assessed and number of medication will be identified.

Time frame
initally
3

EuroQual 5 Dimensions Questionnaire (EQ5D5L)

EQ5D5L will be assessed from each participant to identify their quality of life.

Time frame
initially, 6 months, one year.
4

patient reported outcome measure associated with the lone bone fracture

patient reported outcome measure will be assessed by each patient that is associated with the lone bone fracture

Time frame
initially, 6 months, one year.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Department of Trauma and Reconstructive Surgery at Eberhard Karls University Tuebingen, BG Klinik Tu

Lead sponsor

BG Klinik Murnau

Collaborator

BG Trauma Center Ludwigshafen

Collaborator

BG Klinikum Duisburg

Collaborator

BG Klink Hamburg

Collaborator

Unfallkrankenhaus Berlin

Collaborator

BG Ambulanz Bremen

Collaborator

Bundeswehrkrankenhaus Ulm

Collaborator

Paracelsus Universität Salzburg

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: